Researcher Profile

David E. Axelrod, PhD

Professor of Genetics
School of Arts and Sciences
Rutgers, The State University of New Jersey

Nelson Biology Laboratories
604 Allison Road
Piscataway, NJ 08854

Phone: (732) 445-2011
Email: axelrod@biology.rutgers.edu


Research Program Alignment

Membership Type: Associate


Research Interests

  • Cellular and molecular oncology
  • Tumor heterogeneity and progression
  • Diagnosis and prognosis of human breast cancer by computer-aided image analysis
  • Mathematical modeling and computer simulation of breast and colon cancer progression

Selected Publications

Prognosis for Survival of Young Women with Breast Cancer by Quantitative p53 Immunohistochemistry Axelrod DE, Shah K, Yang Q & Haffty BG Cancer and Clinical Oncology 2012 1: 2012; 52-64.

Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast. Miller NA, Chapman JA, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Lickley HL, Axelrod DE. Cancer Inform. 2010 Sep 7;9:209-16.

Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors. Axelrod DE, Miller N, Chapman JA. Biomed Inform Insights. 2009 Jan 1;2:11-18.

Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Pienta KJ, McGregor N, Axelrod R, Axelrod DE. Transl Oncol. 2008 Dec;1(4):158-64.

Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast. Axelrod DE, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Yuan Y, Fu Y, Chapman JA. Cancer Inform. 2008;6:99-109. Epub 2008 Mar 1.

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment. Chapman JA, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Axelrod DE. BMC Cancer. 2007 Sep 10;7:174.

Histopathology as a predictive biomarker: strengths and limitations. Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD. J Nutr. 2006 Oct;136(10):2673S-5S. No abstract available.

Evolution of cooperation among tumor cells. Axelrod R, Axelrod DE, Pienta KJ. Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13474-9. Epub 2006 Aug 28.

Breast cancer prognosis by combinatorial analysis of gene expression data. Alexe G, Alexe S, Axelrod DE, Bonates TO, Lozina II, Reiss M, Hammer PL. Breast Cancer Res. 2006;8(4):R41.

Logical analysis of diffuse large B-cell lymphomas. Alexe G, Alexe S, Axelrod DE, Hammer PL, Weissmann D. Artif Intell Med. 2005 Jul;34(3):235-67.

About-weekly variations in nocturia. Cornélissen G, Axelrod DE, Halberg F. Biomed Pharmacother. 2004 Oct;58 Suppl 1:S140-4.

Evaluation of pathways for progression of heterogeneous breast tumors. Sontag L, Axelrod DE. J Theor Biol. 2005 Jan 21;232(2):179-89.

Progression of heterogeneous breast tumors. Subramanian B, Axelrod DE. J Theor Biol. 2001 May 7;210(1):107-19.

A monthly period of symptoms associated with benign prostatic hyperplasia. Axelrod DE. Urology. 2000 Mar;55(3):436.

Assessing genetic markers of tumour progression in the context of intratumour heterogeneity. Chapman JA, Wolman E, Wolman SR, Remvikos Y, Shackney S, Axelrod DE, Baisch H, Christensen IJ, White RA, Liebovitch LS, Moore DH, Waldman FM, Cornelisse CJ, Shankey TV. Cytometry. 1998 Jan 1;31(1):67-73.

The content for this Research Profile is maintained by Paul Novembre (novembre@cinj.rutgers.edu)